BARROW ROBERT (Chief Executive Officer) sold 3.1% of their position (25.80K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $252.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/26/2025ACC: 0001193125-25-220847
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-25.80K
Net shares
Net seller
$252.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
25.80K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−25.80K
Price / share
$9.77
Trade value
$252.04K
% of position
3.1%
9/25/2025
830.07K→804.27K
Total
Net shares
−25.80K
Net value
-$252.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/25/2025 | S · Sale | −25.80K | $9.77 | $252.04K | 3.1% | 830.07K | 804.27K |
| Total | −25.80K | -$252.04K | ||||||
Derivative Transactions0
No derivative transactions reported